A historic shift in Canadian drug policy has occurred, as the regulators allow the legalization of psilocybin mushrooms for therapeutic purposes. Previously, these substances were severely restricted, but a increasing body of research suggests they may offer benefits for emotional issues like depression. This development represents a key step towar